CLOV
Clover Health Investments, Corp. (Russell 2000)
Healthcare — Healthcare Plans
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
None
4 analysts
$4.23
$-0.08 (-1.86%)
Target:
$5.38
(27.1%)
Price History
52-Week Range
Sign in to add CLOV to a watchlist or set price alerts.
Fundamentals
| Market Cap | $2.25B |
| P/E Ratio (TTM) | - |
| Forward P/E | 28.20 |
| EPS (TTM) | $-0.05 |
| Dividend Yield | - |
| Profit Margin | -0.74% |
| Revenue Growth | 55.60% |
| ROE | -5.10% |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | $5.38 |
| Analysts | 4 |
| Next Earnings | Aug 5, 2026 AMC |
| Indexes | Russell 2000 |
Technical Indicators
| RSI (14) | 31.2 |
| Beta | 2.48 |
| SMA 20 | $4.50 |
| SMA 40 | $4.42 |
| 52-Week High | $5.59 |
| 52-Week Low | $1.58 |
| 50-Day Avg | $4.40 |
| 200-Day Avg | $3.31 |
| Avg Volume | $4.38M |
| Volume | $3.58M |
Performance Analysis
NEUTRALCLOV presents a mixed picture with both positive and negative indicators.
~
Trading at 66% of its 52-week range.
~
RSI at 31.2 is in neutral territory.
~
Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
+
Strong revenue growth of 55.6% year-over-year.
-
Operating at a loss with -0.7% margin.
~
Wall Street consensus is "none" from 4 analysts.
+
Average analyst target of $5.38 implies 27.1% upside.
Recent News
Loading news...
Last updated: Oct 01, 2026 21:01 UTC
Back to Screener Export Report